epigallocatechin gallate has been researched along with Breast Neoplasms in 122 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (3.28) | 18.2507 |
| 2000's | 43 (35.25) | 29.6817 |
| 2010's | 66 (54.10) | 24.3611 |
| 2020's | 9 (7.38) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, TH; Cui, QC; Dou, QP; Huo, C; Yang, H | 1 |
| Fan, L; Song, Y; Xie, L; Yi, J; Zhao, L; Zhao, M | 1 |
| Gao, Y; Guan, YQ; He, J; Jiang, S; Wang, X; Yin, L; You, R; Zhang, LK | 1 |
| He, D; Kong, L; Li, X; Meng, X; Xing, L; Yu, J; Zhang, S; Zhao, H; Zhao, X; Zheng, M; Zhou, Z; Zhu, W | 1 |
| Alexiou, A; Athanasiou, E; Gatsis, A; Kamal, MA; Kanatas, P; Karaoulani, C; Kelesis, I; Oikonomou, ME; Papageorgiou, S; Saitani, EM; Stouras, I; Tsagkaris, C; Vasileiou, M; Verras, GI; Vlassi, DA | 1 |
| Burgos, V; Maria, DA; Marín, V; Pardi, P; Paz, C; Pérez, R | 1 |
| Guo, H; Liu, J; Long, W; Qi, J; Sheng, J; Shi, W; Wang, Y; Xu, Y | 1 |
| Abd Eldaim, MA; Abdallah, AEM; Abdel-Daim, MM; Abdelaziz, SAM; Abdul Rashid, S; Abdullah, AS; Abdullah, LC; Abramson, MJ; Ahmed, HB; Ahmed, MM; Ahn, YC; Alexander, DC; Ando, T; Angelone, AM; Anglani, F; Ap, Y; Arthanari, SK; Axelrad, C; Bai, S; Bakonyi, P; Barnes, E; Beckmann, NA; Bélafi-Bakó, K; Bennett, CM; Bestha, RM; Bitsch, RG; Bradley, CA; Bu, Y; Calò, LA; Cañedo-Villaroya, E; Carlson, L; Caruso, S; Casado-Flores, J; Ceol, M; Cesarino, I; Chen, IL; Chen, R; Chen, X; Chilvers, MI; Cho, WK; Choong, TSY; Conceição-Neto, N; Culver, EL; Dai, X; de Lama Caro-Patón, G; De Rosa, I; Del Prete, D; Dharmage, SC; Dimitriadis, E; Dittakavi, S; Dobrowolski, JC; Edin, S; Elgarawany, GE; Emam, HE; Emmens, RW; Erbas, B; Erwich, JJHM; Farghali, M; Feng, L; Funston, RN; Gabler, NK; Gale, P; Ganesh, M; Gao, J; Gao, L; Gao, X; García-Salido, A; Gatto, R; Gautam, S; Ge, C; Ghogomu, SM; Gianesello, L; Gonçales, VR; Gooch, JL; Gooding, JJ; Gourley, GG; Gu, H; Gu, X; Gu, Z; Guerreri, M; Guillén, M; Hazzaa, SM; Heylen, E; Hicks, R; Hong, X; Hoshi, M; Hu, B; Hu, LX; Hu, R; Hu, S; Huang, J; Huang, K; Hubbard, WB; Hui, J; Hwang, NY; Iannacci, J; Ianus, A; Iglesias-Bouzas, MI; Ihara, I; Iwasaki, M; Jaeger, S; Kandel, YR; Karpińska, G; Kim, HK; Klopfenstein, TJ; Knorr, D; Koók, L; Kotb, S; Kruithof, S; Larsson, P; Laurence, C; Leng, J; Li, H; Li, J; Li, Q; Li, S; Li, X; Li, Z; Lian, J; Liang, JX; Liang, X; Lighaam, LC; Lin, CW; Lin, HC; Lin, J; Ling, A; Liu, J; Liu, P; Liu, YS; Ljuslinder, I; Lo, GH; Lodge, CJ; Löfgren-Burström, A; Lowe, AJ; Lu, M; Lu, N; Lucero-Prisno, DE; Luebbe, KM; Luo, X; Ma, Z; Maes, P; Makuch, M; Malekbala, MR; Mao, Z; Martínez-Romera, I; Marzo, G; Mathew, FM; Mattei, A; Matthijnssens, J; Mayumi, M; Morita, N; Mueller, DS; Mullangi, R; Mummolo, S; Murthi, P; Myte, R; Nabeshima, T; Nakamoto, K; Nehdi, IA; Nemestóthy, N; Niessen, HWM; Noh, JM; Nota, A; Nunes, D; Oh, D; Öhlund, D; Olsen, KM; Ono, H; Osawa, Y; Palmqvist, R; Palombo, M; Park, M; Patience, JF; Peng, Y; Perng, DS; Persano, A; Priante, G; Prince, SJ; Pulipati, S; Pyo, H; Qiu, X; Quan, J; Quaranta, F; Quinzi, V; Rademacher, CJ; Rajaraman, G; Rashid, U; Rauch, JC; Rector, A; Remmerswaal, EBM; Ren, R; Rispens, T; Rocha, GS; Saad, NM; Saito, K; Salamova, A; Sarfaraz, K; Satoshi, A; Schnellmann, RG; Scholpa, NE; Schonhoff, M; Schwartz, KJ; Schwarze, M; Schweer, WP; Seiichi, Y; Serrano-González, A; Severino, J; Shemesh, N; Shi, ZQ; Shike, DW; Shim, YM; Siciliano, PA; Siebenrock, KA; Silva, MKL; Smith, DL; Soltani, S; Song, YM; Spry, ML; Stalker, LA; Stokes, RS; Sullivan, PG; Sun, JM; Sun, S; Svanes, C; Syo, K; Tai, CM; Takashima, S; Tashita, C; Taurino, A; Ten Berge, IJM; Tenuta, AU; Teo, SH; Tilley, RD; Trivedi, RK; Umetsu, K; Unger, PA; van Bruggen, R; van Ham, SM; Van Ranst, M; Vanitha, J; Vekaria, HJ; Venier, M; Venkateshwaran, K; Venkert, A; Vermeulen, E; Wan, C; Wang, H; Wang, N; Wang, P; Wang, T; Wang, X; Wang, Y; Wise, KA; Wolbink, GJ; Wu, J; Wu, P; Wu, S; Wu, Y; Xia, Q; Xin, W; Xiong, Q; Xu, H; Xu, P; Xue, S; Yamamoto, Y; Yamashiro, T; Yan, F; Yan, H; Yan, S; Yan, Y; Yang, JM; Yang, L; Yang, P; Ye, W; Yeh, JH; Yinda, CK; Ying, GG; Ying, L; Yoon, HG; Yu, H; Zainuddin, M; Zakkula, A; Zeller, M; Zeng, Y; Zha, J; Zhang, F; Zhang, H; Zhang, M; Zhang, Q; Zhang, S; Zhang, T; Zhang, Z; Zhao, C; Zhao, J; Zhao, Y; Zhong, Q; Zhu, J; Zingmark, C; Zo, JI; Zou, Y | 1 |
| Chen, HY; Chiang, YF; Hsia, SM; Huang, YJ; Wang, KL | 1 |
| Martel, F; Romano, A | 1 |
| Huang, Y; Liang, Q; Pang, Q; Sheng, J; Wang, X; Xiang, Z; Zhang, D; Zhang, X; Zhu, Q; Zi, C | 1 |
| Andò, S; Augimeri, G; Barone, I; Bonofiglio, D; Catalano, S; De Amicis, F; Giordano, C; Lanzino, M; Montalto, FI | 1 |
| Bonucci, M; Fioranelli, M; Lotti, T; Roccia, MG | 1 |
| Farabegoli, F; Govoni, M; Papi, A; Spisni, E | 1 |
| Erfanian, S; Hosseini, A; Moradzadeh, M; Rezaei, H | 1 |
| Li, Y; Meeran, SM; Tollefsbol, TO | 1 |
| Gianfredi, V; Moretti, M; Nucci, D; Vannini, S; Villarini, M | 1 |
| Dostal, AM; Emory, TH; Kurzer, MS; Le, CT; Lee, E; Samavat, H; Swenson, K; Torkelson, CJ; Ursin, G; Wang, R; Wu, AH; Yang, CS; Yee, D; Yu, MC; Yuan, JM | 1 |
| Bragazzi, NL; Gianfredi, V; Izzotti, A; Moretti, M; Nucci, D; Vannini, S; Villarini, M | 1 |
| Aanei, CM; Campos, L; Filippi, A; Ganea, C; Mocanu, MM; Nagy, P; Picot, T; Szöllősi, J | 1 |
| Goormaghtigh, E; Mignolet, A; Wood, BR | 1 |
| Ding, J; Jiang, L; Liang, T; Min, Q; Zhu, JJ | 1 |
| Das, SK; Emdad, L; Fisher, PB; Kumar, BNP; Kundu, SC; Mahto, MK; Mandal, M; Pathak, A; Puvvada, N; Rajput, S; Reis, RL; Sarkar, S; Yallapu, MM | 1 |
| Du, GH; Fu, W; Liu, AL; Pang, X; Wang, J; Xu, L; Zhao, Y | 1 |
| Chong, Y; Jung, W; Kim, MK; Shin, S | 1 |
| Guo, L; Hu, Y; Ji, D; Luo, X; Shang, D; Zhang, L | 1 |
| Ding, J; Jiang, L; Liang, T; Min, Q; Yao, Z; Zhu, JJ | 1 |
| Hackman, RM; Mackenzie, GG; Mao, L; Wang, Y; Wei, R; Xu, P; Zheng, X | 1 |
| Heidegger, H; Hofmann, S; Jeschke, U; Koch, JG; Mahner, S; Marahrens, P; Phan-Brehm, T; Richter, DU; Schröder, L; Vilsmeier, T | 1 |
| Cebula-Obrzut, B; Fabianowska-Majewska, K; Kaufman-Szymczyk, A; Lubecka, K; Smolewski, P; Szemraj, J | 1 |
| Bhargava, S; Gudem, S; Kulhari, H; Pooja, D; Radhakrishnan, R; Ramakrishna, S; Ravuri, HG | 1 |
| Donejko, M; Galicka, E; Niczyporuk, M; Przylipiak, A | 1 |
| Cai, Q; de Pace, RC; Fan, Z; Gao, W; Liu, X; Nie, S; Pan, X; Sun, M; Wang, S; Zhang, J | 1 |
| Berindan-Neagoe, I; Braicu, C; Gherman, CD; Irimie, A | 1 |
| Araújo, I; Correia-Branco, A; Costa, T; Faria, A; Keating, E; Martel, F; Moreira, L | 1 |
| Chapman, SE; Davison, CA; Diener, J; Durbin, SM; Leevy, WM; Schafer, ZT; Thau, MR; Wathen, C; Zellmer, VR | 1 |
| Yiannakopoulou, ECh | 1 |
| Jang, JY; Jeon, YK; Kim, CW; Lee, JK | 1 |
| Deb, G; Gupta, S; Limaye, AM; Thakur, VS | 1 |
| Faratian, D; Harrison, DJ; Huang, R; Langdon, SP; Sims, AH; Thomas, JS; Wilson, D | 1 |
| Deb, G; Limaye, AM; Manjegowda, CM | 1 |
| Ciavarella, C; Farabegoli, F; Govoni, M; Orlandi, M; Papi, A | 1 |
| Al-Saleh, N; Asfar, S; Oteifa, M; Raghupathy, R; Saleh, F | 1 |
| Chen, M; Chen, R; Shi, Z; Wang, S; Wang, Y; Zhong, Z | 1 |
| Burlando, B; Cain, SM; Magnelli, V; Marchetti, C; Martinotti, S; Ranzato, E; Snutch, TP; Waheed, Z | 1 |
| Akare, UR; Bandaru, S; Dunna, NR; Gutlapalli, VR; Nayarisseri, A; Rajadhyax, S; Yadav, M | 1 |
| Mahalingaiah, PK; Singh, KP; Treas, JN; Tyagi, T | 1 |
| Deb, M; Kar, S; Parbin, S; Patra, SK; Pradhan, N; Rakshit, M; Rath, SK; Sengupta, D; Shilpi, A | 1 |
| Koyakutty, M; Menon, D; Mony, U; Narayanan, S; Paul-Prasanth, B; Vijaykumar, DK | 1 |
| Bedell, S; Dostal, AM; Kurzer, MS; Le, C; Samavat, H; Swenson, K; Torkelson, C; Ursin, G; Wang, R; Wu, AH; Yuan, JM | 1 |
| Blancafort, A; Brugada, R; Campuzano, Ò; Carrión-Salip, D; Giró-Perafita, A; Gómez-Miragaya, J; González-Suárez, E; Massaguer, A; Oliveras, G; Palafox, M; Palomeras, S; Puig, T; Turrado, C | 1 |
| Bedell, S; Dostal, AM; Emory, TH; Gross, MD; Kurzer, MS; Le, CT; Samavat, H; Torkelson, CJ; Ursin, G; Wang, R; Wu, AH; Yang, CS; Yee, D; Yu, MC; Yuan, JM | 1 |
| Bao, B; Ding, J; He, Z; Jiang, L; Li, R; Xue, J; Yao, J; Zhu, JJ | 1 |
| Chen, G; Jia, L; Kong, L; Li, X; Meng, X; Sun, X; Xing, L; Yu, J; Zhao, H; Zhao, X; Zhu, W | 1 |
| Ding, J; Du, Y; Liu, JY; Tang, J; Zhou, Y | 1 |
| Han, S; Pan, X; Song, Z; Wang, M; Zhao, B | 1 |
| Chen, G; Jia, L; Meng, X; Sun, X; Xing, L; Yu, J; Zhao, H; Zhao, X; Zheng, M; Zhu, W | 1 |
| Nowakowska, A; Tarasiuk, J | 1 |
| Buckhaults, P; Cui, X; Li, Y; Tollefsbol, TO | 1 |
| Inoue, M; Koh, WP; Robien, K; Van Den Berg, DJ; Wang, R; Yu, MC | 1 |
| Cao, XL; Ma, XF; Tian, WX; Wang, Y; Zhang, SY; Zheng, CG | 1 |
| Menzies, AR; Rosengren, RJ; Scandlyn, MJ; Somers-Edgar, TJ; Stuart, EC | 1 |
| Hsieh, TC; Wu, JM | 1 |
| Chan, SH; Cheng, CH; Cheng, GY; Cheung, F; Chui, CH; Gambari, R; Ho, KP; Kok, SH; Lam, KH; Lam, WS; Lau, FY; Tang, JC; Wong, RS | 1 |
| Banerji, A; Chatterjee, A; Choudhury, PR; Das, S; Dutta, A; Moulik, S; Roy, M; Sen, T | 1 |
| Fan, B; Han, G; Wei, L; Zhang, J; Zhang, Y; Zhou, X; Zhou, Y | 1 |
| Baba, K; Hara, Y; Iida, K; Kawaratani, Y; Kushima, Y; Nagaoka, Y; Sakaguchi, M; Shirahama, T; Uesato, S | 1 |
| Hua, H; Jiang, Y; Li, M; Liu, D; Luo, T; Wang, J; Wang, R; Xu, L; Yin, Y; Zhang, Y | 1 |
| Bartolini, G; Farabegoli, F; Orlandi, M; Ostan, R; Papi, A | 1 |
| Dou, QP | 1 |
| Inoue, M; Iwasaki, M; Miura, T; Sasazuki, S; Sawada, N; Shimazu, T; Tsugane, S; Willett, WC; Yamaji, T | 1 |
| Farabegoli, F; Orlandi, M; Papi, A | 1 |
| Chatterjee, A; Dutta, A; Sen, T | 1 |
| Ahn, SG; Choi, HS; Kim, SA; Tran, PL; Yoon, JH | 1 |
| Chan, TH; Chen, D; Dou, QP; Landis-Piwowar, K | 1 |
| Jarvis, RM; Rosengren, RJ; Stuart, EC | 1 |
| Li, Y; Meeran, SM; Tollefsbol, TO; Yuan, YY | 1 |
| Blancafort, A; Brugada, R; Campuzano, O; Colomer, R; Gómez-Cabello, D; López-Rodríguez, ML; Oliveras, G; Puig, T; Urruticoechea, A | 1 |
| Chatterjee, A; Sen, T | 1 |
| Chan, TH; Meeran, SM; Patel, SN; Tollefsbol, TO | 1 |
| Hsu, YC; Liou, YM | 1 |
| Choudhary, S; Odoi, A; Rathore, K; Wang, HC | 1 |
| Duan, H; Hou, A; Hsieh, TC; Huang, Y; Jiang, P; Jin, S; Li, J; Liu, K; Liu, Q; Luan, J; Qu, Z; Wan, X; Wang, F; Wang, S; Wang, Y; Wu, E; Yang, C; Yu, P; Zhang, G; Zhang, L; Zhang, Y | 1 |
| Choudhary, S; Donnell, RL; Sood, S; Wang, HC | 1 |
| Andò, S; Aquila, S; Avena, P; Bonofiglio, D; De Amicis, F; Fuqua, SA; Mauro, L; Russo, A; Santoro, M; Tramontano, D; Vivacqua, A | 1 |
| Beatty, P; Brooks, MN; Elashoff, D; Elashoff, R; Go, VL; Heber, D; Sartippour, MR; Zhang, L | 1 |
| Deguchi, H; Fujii, T; Koga, T; Nakagawa, S; Shirouzu, K | 1 |
| Lim, JT; Masuda, M; Suzui, M; Weinstein, IB | 1 |
| Rosengren, RJ | 1 |
| Katiyar, SK; Mittal, A; Pate, MS; Tollefsbol, TO; Wylie, RC | 1 |
| Bray, BJ; Chisholm, K; Rosengren, RJ | 1 |
| Guo, S; Sonenshein, GE; Taylor, C; Yang, S | 1 |
| Bigelow, RL; Cardelli, JA | 1 |
| Wu, AH; Yu, MC | 1 |
| Kim, J; Paulson, KE; Rieger-Christ, KM; Summerhayes, IC; Wazer, DE; Yee, AS; Zhang, X | 1 |
| Gaddipati, JP; Maheshwari, RK; Sharma, A; Singh, AK; Thangapazham, RL; Warren, J | 1 |
| Li, L; Ma, X; Tian, H; Zhao, X | 1 |
| Rosengren, RJ; Scandlyn, MJ; Stuart, EC | 1 |
| Bode, AM; Choi, BY; Choi, HS; Dong, Z; Ermakova, SP; Kang, BS; Ma, WY; Schuster, TF | 1 |
| Ling, MT; Wang, X; Wong, YC; Zhang, X | 1 |
| Blumberg, JB; Boucher, Y; Eisenberg, DM; Held, KD; Jain, RK; Kashiwagi, S; Lawenda, BD; Loeffler, JS; Niemierko, A; Silverstein, JR; Smith, DE; Xu, L | 1 |
| Chan, WH; Hsuuw, YD | 1 |
| Chan, TH; Chen, D; Dou, QP; Huo, C; Landis-Piwowar, KR; Milacic, V; Shi, G | 1 |
| Larsen, L; Rosengren, RJ; Stuart, EC | 1 |
| Chen, WJ; Lin, CC; Lin, JK; Pan, MH | 1 |
| Andrews, LG; Berletch, JB; Katiyar, SK; Liu, C; Love, WK; Tollefsbol, TO | 1 |
| Belguise, K; Guo, S; Sonenshein, GE | 1 |
| Beckman, BS; Burow, ME; Curiel, TJ; Elliott, S; Tang, Y; Zhao, DY; Zhao, W | 1 |
| Brunet, J; Casals, G; Colomer, R; Haro, D; Marrero, PF; Menéndez, JA; Pétriz, J; Porta, R; Puig, T; Relat, J; Vázquez-Martín, A | 1 |
| Eddy, SF; Kane, SE; Sonenshein, GE | 1 |
| Buxton, IL; Javed, MA; Law, WE; Rumjahn, SM; Wong, N | 1 |
| Maheshwari, RK; Passi, N; Thangapazham, RL | 1 |
| Barbi, C; Farabegoli, F; Lambertini, E; Piva, R | 1 |
| Le Nedelec, MJ; Rosengren, RJ; Scandlyn, MJ; Somers-Edgar, TJ; Stuart, EC; Valentine, SP | 1 |
| Weinstein, B | 1 |
| Guo, J; Hiipakka, RA; Kokontis, JM; Liao, S; Umekita, Y | 1 |
| Higashi, Y; Imai, K; Nakachi, K; Suemasu, K; Suga, K; Takeo, T | 1 |
| Chen, KY; Chen, ZP; Ho, CT; Schell, JB | 1 |
| Fujiki, H; Imai, K; Matsuyama, S; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M | 1 |
| Cobrinik, D; Liberto, M | 1 |
| Go, VL; Heber, D; Lu, Q; Ma, J; Nguyen, M; Sartippour, MR | 1 |
| Bradlow, HL; Sepkovic, DW | 1 |
14 review(s) available for epigallocatechin gallate and Breast Neoplasms
| Article | Year |
|---|---|
The Association Between the Risk of Breast Cancer and Epigallocatechin- 3-Gallate Intake: A Literature Review of a Potential Chemopreventive Agent.
Topics: Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Catechin; ErbB Receptors; Female; Humans; Tea | 2022 |
The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment.
Topics: Apoptosis; Breast; Breast Neoplasms; Catechin; Female; Humans; Polyphenols; Signal Transduction; Tea | 2023 |
Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Amylose; Anaerobiosis; Animals; Anti-Bacterial Agents; Anura; Arginase; Arthritis, Rheumatoid; Asthma; Atmosphere; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Bioelectric Energy Sources; Biofilms; Biofuels; Biomarkers; Biopolymers; Bioreactors; Brain; Brain Injuries, Traumatic; Breast Neoplasms; Calibration; Carbon Tetrachloride; Caspase 3; Catalysis; Catechin; Cations; Cattle; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Body; Cell Line, Tumor; Cell Plasticity; Chemical and Drug Induced Liver Injury; Chemistry Techniques, Synthetic; China; Chitosan; Chloride Channels; Chromatography, High Pressure Liquid; Chromosome Mapping; Cognition; Cognitive Dysfunction; Cohort Studies; Colitis, Ulcerative; Colloids; Coloring Agents; Congresses as Topic; Correlation of Data; Crystallization; Cyanoacrylates; Cyclohexane Monoterpenes; Cyprinidae; Cytochrome P-450 CYP1A1; Death, Sudden; Dent Disease; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Disease Resistance; Disulfides; Drug Monitoring; Drug Stability; Ecotoxicology; Electricity; Electrodes; Endocytosis; Environmental Exposure; Environmental Monitoring; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Esophageal and Gastric Varices; Esters; Fagopyrum; Female; Ferrosoferric Oxide; Flame Retardants; Flavobacteriaceae; Flow Cytometry; Follow-Up Studies; Formoterol Fumarate; Fusarium; Garlic; Gastrointestinal Hemorrhage; Gene Expression; Genes, Plant; Genetic Markers; Glial Fibrillary Acidic Protein; Gliosis; Global Health; Glutathione Transferase; Glycine max; Gum Arabic; Hemostasis, Endoscopic; Hepatocytes; Hippocampus; Humans; Hydrogen-Ion Concentration; Illinois; Immunoglobulin G; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intraperitoneal; Interleukin-4; Iowa; Iron; Ki-67 Antigen; Kidney; Kinetics; Kynurenine; Lakes; Levofloxacin; Lipid Peroxidation; Lipids; Liver; Liver Cirrhosis, Experimental; Magnetic Fields; Magnetic Iron Oxide Nanoparticles; Male; Manure; Maze Learning; Memory, Short-Term; Metal Nanoparticles; Metals, Heavy; Methane; Mice; Mice, Inbred C57BL; Mice, Knockout; Michigan; Microalgae; Microbial Consortia; Mitochondria; Models, Animal; Models, Chemical; Models, Neurological; Molecular Structure; Molecular Weight; Mutation; Myeloid-Derived Suppressor Cells; NADPH Oxidase 2; Neoplasm Recurrence, Local; Neurites; Neurons; Neuroprotective Agents; NF-kappa B; NIH 3T3 Cells; Nitric Oxide Synthase Type II; Nitrogen; Ohio; Ointments; Ontario; Organelle Biogenesis; Organophosphates; Organophosphorus Compounds; Oxidative Stress; Palladium; Particle Size; Pectins; Phenotype; Phytotherapy; Piperidines; Placenta; Plant Diseases; Plant Extracts; Polymers; Polymorphism, Genetic; Polyphenols; Powders; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Protein Kinase Inhibitors; Protein Structure, Secondary; Proteins; Pyridines; Pyrimidines; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, Lipoxin; Recovery of Function; Recurrence; Reference Standards; Reference Values; Reproducibility of Results; Respiratory Function Tests; Retrospective Studies; Risk; Sensitivity and Specificity; Sewage; Signal Transduction; Sodium Glutamate; Soil; Solanum tuberosum; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spermatozoa; STAT3 Transcription Factor; Sulfamethoxazole; Tea; Temperature; Thermodynamics; Thrombin; Treatment Outcome; Triazoles; United States; Viscosity; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; White Matter; Wisconsin; X-Ray Diffraction; Zea mays | 2013 |
Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Catechin; Endometrial Neoplasms; Epithelial-Mesenchymal Transition; Female; Humans; NF-E2-Related Factor 2; Ovarian Neoplasms; Protective Agents; Tea | 2020 |
The Role of EGCG in Breast Cancer Prevention and Therapy.
Topics: Animals; Antineoplastic Agents; Antioxidants; Breast Neoplasms; Catechin; Cell Proliferation; Female; Humans; Mammary Neoplasms, Experimental; Vascular Endothelial Growth Factors | 2021 |
Nutraceuticals in the Mediterranean Diet: Potential Avenues for Breast Cancer Treatment.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Catechin; Cell Cycle Checkpoints; Diet, Mediterranean; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Inflammation; Polyphenols; Resveratrol; Retinoids | 2021 |
In vitro Biological Effects of Sulforaphane (SFN), Epigallocatechin-3-gallate (EGCG), and Curcumin on Breast Cancer Cells: A Systematic Review of the Literature.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Catechin; Cell Cycle; Cell Line, Tumor; Curcumin; Epigenesis, Genetic; Female; Humans; Isothiocyanates; Sulfoxides; Telomerase | 2017 |
Sulforaphane and Epigallocatechin Gallate Restore Estrogen Receptor Expression by Modulating Epigenetic Events in the Breast Cancer Cell Line MDA-MB-231: A Systematic Review and Meta-Analysis.
Topics: Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Catechin; Cell Line, Tumor; Epigenesis, Genetic; Female; Gene Expression; Humans; Isothiocyanates; Nutrigenomics; Receptors, Estrogen; Sulfoxides | 2017 |
[Anti-cancer properties epigallocatechin-gallate contained in green tea].
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Breast Neoplasms; Catechin; Cell Transformation, Neoplastic; Female; Gastrointestinal Neoplasms; Humans; Male; Neoplasms; Skin Neoplasms; Tea | 2013 |
Effect of green tea catechins on breast carcinogenesis: a systematic review of in-vitro and in-vivo experimental studies.
Topics: Animals; Breast Neoplasms; Carcinogenesis; Catechin; Cells, Cultured; Female; Flavonoids; Humans; Plant Extracts; Tea | 2014 |
Catechins and the treatment of breast cancer: possible utility and mechanistic targets.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catechin; Female; Humans; Tamoxifen; Tea | 2003 |
Tea, hormone-related cancers and endogenous hormone levels.
Topics: Animals; Breast Neoplasms; Catechin; Female; Hormones; Humans; Male; Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Risk Factors; Tea | 2006 |
Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
Topics: Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Catechin; Cell Cycle; Female; Humans; Male; Prostatic Neoplasms; Tea; Urokinase-Type Plasminogen Activator | 2006 |
Relevance of the concept of oncogene addiction to hormonal carcinogenesis and molecular targeting in cancer prevention and therapy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Catechin; Female; Humans; Male; Neoplasms, Hormone-Dependent; Oncogenes; Prostatic Neoplasms; Sulindac | 2008 |
7 trial(s) available for epigallocatechin gallate and Breast Neoplasms
| Article | Year |
|---|---|
Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical Trial.
Topics: Breast Neoplasms; Catechin; Female; Humans; Middle Aged; Radiodermatitis; Treatment Outcome | 2022 |
Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Amylose; Anaerobiosis; Animals; Anti-Bacterial Agents; Anura; Arginase; Arthritis, Rheumatoid; Asthma; Atmosphere; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Bioelectric Energy Sources; Biofilms; Biofuels; Biomarkers; Biopolymers; Bioreactors; Brain; Brain Injuries, Traumatic; Breast Neoplasms; Calibration; Carbon Tetrachloride; Caspase 3; Catalysis; Catechin; Cations; Cattle; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Body; Cell Line, Tumor; Cell Plasticity; Chemical and Drug Induced Liver Injury; Chemistry Techniques, Synthetic; China; Chitosan; Chloride Channels; Chromatography, High Pressure Liquid; Chromosome Mapping; Cognition; Cognitive Dysfunction; Cohort Studies; Colitis, Ulcerative; Colloids; Coloring Agents; Congresses as Topic; Correlation of Data; Crystallization; Cyanoacrylates; Cyclohexane Monoterpenes; Cyprinidae; Cytochrome P-450 CYP1A1; Death, Sudden; Dent Disease; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Disease Resistance; Disulfides; Drug Monitoring; Drug Stability; Ecotoxicology; Electricity; Electrodes; Endocytosis; Environmental Exposure; Environmental Monitoring; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Esophageal and Gastric Varices; Esters; Fagopyrum; Female; Ferrosoferric Oxide; Flame Retardants; Flavobacteriaceae; Flow Cytometry; Follow-Up Studies; Formoterol Fumarate; Fusarium; Garlic; Gastrointestinal Hemorrhage; Gene Expression; Genes, Plant; Genetic Markers; Glial Fibrillary Acidic Protein; Gliosis; Global Health; Glutathione Transferase; Glycine max; Gum Arabic; Hemostasis, Endoscopic; Hepatocytes; Hippocampus; Humans; Hydrogen-Ion Concentration; Illinois; Immunoglobulin G; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intraperitoneal; Interleukin-4; Iowa; Iron; Ki-67 Antigen; Kidney; Kinetics; Kynurenine; Lakes; Levofloxacin; Lipid Peroxidation; Lipids; Liver; Liver Cirrhosis, Experimental; Magnetic Fields; Magnetic Iron Oxide Nanoparticles; Male; Manure; Maze Learning; Memory, Short-Term; Metal Nanoparticles; Metals, Heavy; Methane; Mice; Mice, Inbred C57BL; Mice, Knockout; Michigan; Microalgae; Microbial Consortia; Mitochondria; Models, Animal; Models, Chemical; Models, Neurological; Molecular Structure; Molecular Weight; Mutation; Myeloid-Derived Suppressor Cells; NADPH Oxidase 2; Neoplasm Recurrence, Local; Neurites; Neurons; Neuroprotective Agents; NF-kappa B; NIH 3T3 Cells; Nitric Oxide Synthase Type II; Nitrogen; Ohio; Ointments; Ontario; Organelle Biogenesis; Organophosphates; Organophosphorus Compounds; Oxidative Stress; Palladium; Particle Size; Pectins; Phenotype; Phytotherapy; Piperidines; Placenta; Plant Diseases; Plant Extracts; Polymers; Polymorphism, Genetic; Polyphenols; Powders; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Protein Kinase Inhibitors; Protein Structure, Secondary; Proteins; Pyridines; Pyrimidines; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, Lipoxin; Recovery of Function; Recurrence; Reference Standards; Reference Values; Reproducibility of Results; Respiratory Function Tests; Retrospective Studies; Risk; Sensitivity and Specificity; Sewage; Signal Transduction; Sodium Glutamate; Soil; Solanum tuberosum; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spermatozoa; STAT3 Transcription Factor; Sulfamethoxazole; Tea; Temperature; Thermodynamics; Thrombin; Treatment Outcome; Triazoles; United States; Viscosity; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; White Matter; Wisconsin; X-Ray Diffraction; Zea mays | 2013 |
A Randomized Controlled Trial of Green Tea Extract Supplementation and Mammographic Density in Postmenopausal Women at Increased Risk of Breast Cancer.
Topics: Aged; Anticarcinogenic Agents; Antioxidants; Body Mass Index; Breast; Breast Density; Breast Neoplasms; Catechin; Catechol O-Methyltransferase; Dietary Supplements; Double-Blind Method; Female; Genotype; Humans; Mammography; Middle Aged; Plant Extracts; Postmenopause; Tamoxifen; Tea | 2017 |
The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial.
Topics: Aged; Anticarcinogenic Agents; Antioxidants; Biomarkers; Breast Density; Breast Neoplasms; Camellia sinensis; Catechin; Dietary Supplements; Double-Blind Method; Female; Food Handling; Hepatic Insufficiency; Humans; Mammary Glands, Human; Middle Aged; Minnesota; Plant Extracts; Plant Leaves; Radiography; Risk Factors; Severity of Illness Index | 2015 |
The Minnesota Green Tea Trial (MGTT), a randomized controlled trial of the efficacy of green tea extract on biomarkers of breast cancer risk: study rationale, design, methods, and participant characteristics.
Topics: Antioxidants; Biomarkers; Breast; Breast Neoplasms; Catechin; Catechol O-Methyltransferase; Double-Blind Method; Estrogens; F2-Isoprostanes; Female; Genotype; Gonadal Steroid Hormones; Humans; Insulin-Like Growth Factor I; Mammography; Middle Aged; Minnesota; Oxidative Stress; Risk Factors; Tea | 2015 |
Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
Topics: Administration, Topical; Adult; Antioxidants; Breast Neoplasms; Catechin; Combined Modality Therapy; Female; Humans; Mastectomy; Middle Aged; Radiodermatitis; Radiotherapy, Adjuvant; Treatment Outcome | 2016 |
Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy.
Topics: Administration, Cutaneous; Adult; Breast; Breast Neoplasms; Catechin; Female; Humans; Mastectomy; Middle Aged; Pain; Pain Management; Prospective Studies; Radiation-Protective Agents; Radiodermatitis; Radiotherapy, Adjuvant; Treatment Outcome; Young Adult | 2016 |
102 other study(ies) available for epigallocatechin gallate and Breast Neoplasms
| Article | Year |
|---|---|
Proteasome inhibition in human breast cancer cells with high catechol-O-methyltransferase activity by green tea polyphenol EGCG analogs.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Catechin; Catechol O-Methyltransferase; Cell Survival; Female; Humans; Prodrugs; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Tea | 2010 |
Suppression of GOLM1 by EGCG through HGF/HGFR/AKT/GSK-3β/β-catenin/c-Myc signaling pathway inhibits cell migration of MDA-MB-231.
Topics: beta Catenin; Blotting, Western; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Movement; Glycogen Synthase Kinase 3 beta; Hepatocyte Growth Factor; Humans; Membrane Proteins; Proto-Oncogene Proteins c-met; Proto-Oncogene Proteins c-myc; Real-Time Polymerase Chain Reaction; Signal Transduction | 2021 |
Multi-ligand modified PC@DOX-PA/EGCG micelles effectively inhibit the growth of ER
Topics: Animals; Antineoplastic Agents; Apoptosis; Biflavonoids; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Carriers; Drug Liberation; Humans; Ligands; Mice, Inbred BALB C; Micelles; Phosphatidylcholines; Proanthocyanidins | 2022 |
The Inhibitory Effect of (-)-Epigallocatechin-3-Gallate on Breast Cancer Progression via Reducing
Topics: Adaptor Proteins, Signal Transducing; Breast Neoplasms; Calcium-Binding Proteins; Catechin; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Neoplasm Proteins | 2019 |
Proliferation of MDA-MB-231 can be suppressed by dimeric-epigallocatechin gallate through competitive inhibition of amphiregulin-epidermal growth factor receptor signaling.
Topics: Amphiregulin; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dimerization; ErbB Receptors; Female; Humans; MCF-7 Cells; Signal Transduction | 2021 |
Possible use of epigallocatechin-3-gallate (EGCG) as prevention of radio dermatitis in radiotherapy treated breast cancer patients.
Topics: Antioxidants; Breast Neoplasms; Catechin; Female; Humans; Radiodermatitis; Treatment Outcome | 2017 |
EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
Topics: Basigin; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Movement; Down-Regulation; ErbB Receptors; Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MCF-7 Cells; Neoplasm Invasiveness; Phenanthrenes; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1 | 2017 |
Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase.
Topics: Antioxidants; Apoptosis; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Survival; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Telomerase | 2017 |
Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Catechin; Cell Line, Tumor; Disease Models, Animal; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Epigenesis, Genetic; Estrogen Receptor alpha; Heterografts; Humans; Isothiocyanates; Mice; Neoplasm Transplantation; Phytochemicals; Sulfoxides; Tamoxifen; Treatment Outcome | 2017 |
Epigallocatechin-3-O-gallate alleviates the malignant phenotype in A-431 epidermoid and SK-BR-3 breast cancer cell lines.
Topics: Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Reactive Oxygen Species | 2018 |
Intracellular investigation on the differential effects of 4 polyphenols on MCF-7 breast cancer cells by Raman imaging.
Topics: Apoptosis; Breast Neoplasms; Catechin; Cytochromes c; Cytoplasm; Cytosol; Gallic Acid; Humans; Lipid Metabolism; MCF-7 Cells; Polyphenols; Resveratrol; Tannins | 2017 |
"Stealth and Fully-Laden" Drug Carriers: Self-Assembled Nanogels Encapsulated with Epigallocatechin Gallate and siRNA for Drug-Resistant Breast Cancer Therapy.
Topics: Animals; Breast Neoplasms; Catechin; Cell Line, Tumor; Drug Carriers; Mice; Nanoparticles; RNA, Small Interfering | 2018 |
Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Chemical Engineering; Drug Carriers; Drug Resistance, Neoplasm; ErbB Receptors; Female; Gold; Humans; Metal Nanoparticles; Mice, Nude; Piperidines; Porosity; Proto-Oncogene Proteins c-akt; Quinazolines; Silicon Dioxide; Tamoxifen; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2018 |
Identification of Estrogen Receptor
Topics: Bayes Theorem; Binding Sites; Biological Products; Breast Neoplasms; Catechin; Databases, Factual; Estrogen Receptor alpha; Female; Genistein; Humans; Inhibitory Concentration 50; Ligands; Machine Learning; MCF-7 Cells; Molecular Docking Simulation; Protein Binding | 2018 |
(-)-Epigallocatechin gallate derivatives reduce the expression of both urokinase plasminogen activator and plasminogen activator inhibitor-1 to inhibit migration, adhesion, and invasion of MDA-MB-231 cells.
Topics: Breast Neoplasms; Catechin; Cell Adhesion; Cell Line, Tumor; Cell Movement; Female; Humans; Neoplasm Invasiveness; Plasminogen; Plasminogen Activator Inhibitor 1; Signal Transduction; Urokinase-Type Plasminogen Activator | 2018 |
Bioinformatics analysis of microarray profiling identifies the mechanism of focal adhesion kinase signalling pathway in proliferation and apoptosis of breast cancer cells modulated by green tea polyphenol epigallocatechin 3-gallate.
Topics: Apoptosis; Breast Neoplasms; Catechin; Cell Adhesion; Cell Proliferation; Computational Biology; Down-Regulation; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Nucleosomes; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Tea | 2018 |
Cascaded Aptamers-Governed Multistage Drug-Delivery System Based on Biodegradable Envelope-Type Nanovehicle for Targeted Therapy of HER2-Overexpressing Breast Cancer.
Topics: Aptamers, Peptide; Breast Neoplasms; Catechin; Cell Line, Tumor; Coated Materials, Biocompatible; Drug Delivery Systems; Female; Gene Expression Regulation, Neoplastic; Humans; Nanostructures; Receptor, ErbB-2 | 2018 |
Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models.
Topics: Animals; Apoptosis; Autophagy; Autophagy-Related Protein 5; Beclin-1; Breast Neoplasms; Caspase 3; Caspase 8; Caspase 9; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Glucose; Glucose Transporter Type 1; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Polyphenols; Tea; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2018 |
Effects of green tea, matcha tea and their components epigallocatechin gallate and quercetin on MCF‑7 and MDA-MB-231 breast carcinoma cells.
Topics: Anticarcinogenic Agents; Antioxidants; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Humans; MCF-7 Cells; Quercetin; Receptors, Estrogen; Tamoxifen; Tea | 2019 |
Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells.
Topics: Apoptosis; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Clofarabine; Cyclin-Dependent Kinase Inhibitor p21; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Genistein; Humans; Inhibitory Concentration 50; Polyphenols; Promoter Regions, Genetic; PTEN Phosphohydrolase; Receptors, Retinoic Acid; Transcription, Genetic; Up-Regulation | 2018 |
Bombesin conjugated solid lipid nanoparticles for improved delivery of epigallocatechin gallate for breast cancer treatment.
Topics: Animals; Antineoplastic Agents; Biological Transport; Bombesin; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Drug Liberation; Female; Humans; Lecithins; Liposomes; Mice, Inbred C57BL; Nanocapsules; Neoplasms, Experimental; Stearic Acids; Surface Properties | 2019 |
Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Catechin; Cell Proliferation; Cell Survival; Chitosan; Female; Humans; Liposomes; MCF-7 Cells; Nanoconjugates | 2013 |
Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells.
Topics: Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Neoplasm Proteins | 2013 |
Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Catechin; Cell Death; Cell Proliferation; Female; Glucose; Humans; Lactic Acid; MCF-7 Cells; Quercetin; Receptors, Estrogen | 2013 |
Antioxidant enzymes mediate survival of breast cancer cells deprived of extracellular matrix.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Ascorbic Acid; Blotting, Western; Breast Neoplasms; Catalase; Catechin; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Survival; Chromans; Extracellular Matrix; Female; Humans; Mice; Mice, Nude; Reactive Oxygen Species; RNA Interference; Superoxide Dismutase; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2013 |
Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization.
Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Chemokine CCL2; Disease Models, Animal; Exosomes; Female; Gene Expression Regulation, Neoplastic; I-kappa B Kinase; I-kappa B Proteins; Macrophage Colony-Stimulating Factor; Macrophages; Mice; MicroRNAs; Paracrine Communication | 2013 |
Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells.
Topics: Acetylation; Breast; Breast Neoplasms; Catechin; Cell Line, Tumor; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Polyphenols; Promoter Regions, Genetic; Tea; Tissue Inhibitor of Metalloproteinase-3 | 2015 |
Increased STAT1 signaling in endocrine-resistant breast cancer.
Topics: Blotting, Western; Breast Neoplasms; Catechin; Cell Survival; Cyclic S-Oxides; Estrogens; Female; Humans; MCF-7 Cells; Polymerase Chain Reaction; Pyridines; STAT1 Transcription Factor; STAT3 Transcription Factor; Tamoxifen; Tyrphostins | 2014 |
Epigallocatechin gallate induces the steady state mRNA levels of pS2 and PR genes in MCF-7 breast cancer cells.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Catechin; Cell Survival; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Receptors, Progesterone; RNA, Messenger; Trefoil Factor-1; Tumor Suppressor Proteins | 2014 |
A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Catechin; Cell Proliferation; Female; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Ligands; MCF-7 Cells; Phenanthrenes; Retinoid X Receptors | 2014 |
Analysis of the effect of the active compound of green tea (EGCG) on the proliferation of peripheral blood mononuclear cells.
Topics: Adult; Breast Neoplasms; Camellia sinensis; Catechin; Cell Proliferation; Cells, Cultured; Female; Humans; Interferon-gamma; Leukocytes, Mononuclear; Plant Extracts | 2014 |
Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Caspases; Catechin; Cell Transformation, Neoplastic; Curcumin; Doxorubicin; Drug Combinations; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; MCF-7 Cells; Phytotherapy; Polyphenols; Signal Transduction | 2014 |
Epigallocatechin-3-gallate elicits Ca2+ spike in MCF-7 breast cancer cells: essential role of Cav3.2 channels.
Topics: Breast Neoplasms; Calcium Channel Blockers; Calcium Channels, T-Type; Catechin; Cell Line, Tumor; Female; Humans; MCF-7 Cells; Membrane Potentials; Patch-Clamp Techniques | 2014 |
Multiclass comparative virtual screening to identify novel Hsp90 inhibitors: a therapeutic breast cancer drug target.
Topics: Adenine; Anisoles; Antineoplastic Agents; Benzamides; Binding Sites; Breast Neoplasms; Catechin; Databases, Chemical; Drug Discovery; Female; Gene Expression; Glycine; Heterocyclic Compounds, 2-Ring; High-Throughput Screening Assays; HSP90 Heat-Shock Proteins; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Indazoles; Ligands; Molecular Docking Simulation; Protein Binding; Pyrazoles; Pyridines; Static Electricity; Structure-Activity Relationship; User-Computer Interface | 2015 |
Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2'-deoxycytidine in human breast cancer cells.
Topics: Azacitidine; Breast Neoplasms; Catechin; Cell Proliferation; Cell Survival; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; MCF-7 Cells; Plant Extracts; Random Amplified Polymorphic DNA Technique; Tea | 2015 |
Mechanisms of DNA methyltransferase-inhibitor interactions: Procyanidin B2 shows new promise for therapeutic intervention of cancer.
Topics: Amino Acid Sequence; Animals; Biflavonoids; Breast; Breast Neoplasms; Catechin; Cell Line, Tumor; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Humans; Mice; Molecular Docking Simulation; Molecular Sequence Data; Proanthocyanidins; Sequence Alignment | 2015 |
Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Caseins; Catechin; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Lactic Acid; Nanoparticles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2015 |
Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Catechin; Cell Adhesion; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fatty Acid Synthase, Type I; Female; Gallic Acid; Humans; Lapatinib; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Naphthalenes; Neoplasm Invasiveness; Neoplasm Transplantation; Quinazolines; Receptor, ErbB-2; Signal Transduction; Sirolimus; Trastuzumab | 2015 |
Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Catechin; Cell Survival; Cell-Penetrating Peptides; Drug Carriers; Female; Fluorescent Dyes; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Nanoparticles; Particle Size; Porosity; Reactive Oxygen Species; Silicon Dioxide; Transplantation, Heterologous | 2015 |
The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells.
Topics: Animals; Anticarcinogenic Agents; Biomarkers, Tumor; Breast Neoplasms; Catechin; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunoenzyme Techniques; Indoles; Insulin Receptor Substrate Proteins; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Prognosis; Pyrroles; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sunitinib; Tea; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2016 |
Estrogen receptor-α36 is involved in epigallocatechin-3-gallate induced growth inhibition of ER-negative breast cancer stem/progenitor cells.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Catechin; Cell Transformation, Neoplastic; Cells, Cultured; Down-Regulation; Estrogen Receptor alpha; Gene Expression; Humans; Neoplastic Stem Cells | 2016 |
Comparative effects of selected plant polyphenols, gallic acid and epigallocatechin gallate, on matrix metalloproteinases activity in multidrug resistant MCF7/DOX breast cancer cells.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Catechin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gallic Acid; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MCF-7 Cells | 2016 |
Combinatorial epigenetic mechanisms and efficacy of early breast cancer inhibition by nutritive botanicals.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brassica; Breast Neoplasms; Carcinogenesis; Catechin; Cell Proliferation; Cells, Cultured; Drug Therapy, Combination; Epigenesis, Genetic; Female; Humans; Isothiocyanates; Mice; Mice, Nude; Sulfoxides; Tea | 2016 |
Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study.
Topics: Aged; Breast Neoplasms; Case-Control Studies; Catechin; Female; Folic Acid; Folic Acid Antagonists; Genotype; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Risk Factors; Tea; Thymidylate Synthase | 2008 |
Novel and potent inhibitors of fatty acid synthase derived from catechins and their inhibition on MCF-7 cells.
Topics: Breast Neoplasms; Catechin; Cell Line, Tumor; Enzyme Inhibitors; Fatty Acid Synthases; Female; Humans; Hydrochloric Acid; Inhibitory Concentration 50; Kinetics; Propionates; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulfuric Acids | 2009 |
A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate.
Topics: Animals; Antineoplastic Agents, Hormonal; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Breast Neoplasms; Catechin; Cell Line, Tumor; Cytochrome P-450 CYP1B1; Down-Regulation; Drug Therapy, Combination; ErbB Receptors; Female; Humans; Mice; Mice, Nude; Protein Kinases; Receptors, Estrogen; Tamoxifen; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2008 |
Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Chromans; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Mice; Models, Biological; Resveratrol; Stilbenes; Superoxide Dismutase; Vitamin E | 2008 |
In vitro cytotoxicity of (-)-EGCG octaacetate on MDAMB-231 and SKHep-1 human carcinoma cells: a pharmacological consideration on prodrug design.
Topics: Acetates; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Prodrugs | 2008 |
Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7.
Topics: Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Fibronectins; Focal Adhesion Kinase 1; Humans; Integrins; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; NF-kappa B; Vitronectin | 2009 |
Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Topics: Animals; Breast Neoplasms; Catechin; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Mice; Microfilament Proteins; Neuropeptides; Phosphoproteins; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; RNA, Messenger; RNA, Small Interfering; Tea; Time Factors; Up-Regulation | 2009 |
Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Catechin; Cell Cycle; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Cell Survival; Female; Humans; Neoplasm Invasiveness; Neuregulin-1; Phosphorylation; Protein Multimerization; Receptor, ErbB-2; Receptor, ErbB-3 | 2009 |
Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 7; Catechin; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Female; Heat-Shock Proteins; Humans; Microtubules; Paclitaxel; Phosphorylation; Poly(ADP-ribose) Polymerases; Unfolded Protein Response; Vinblastine | 2009 |
(-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; bcl-2-Associated X Protein; Breast Neoplasms; Camellia sinensis; Catechin; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression; Humans; Leupeptins; Mitoxantrone; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Plant Extracts; Protease Inhibitors; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Tamoxifen | 2010 |
Molecular mechanisms of green tea polyphenols.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Apoptosis; Biological Availability; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Female; Flavonoids; Humans; Male; Methylation; Mice; Phenols; Polyphenols; Prodrugs; Proteasome Inhibitors; Rats; Tea; Ubiquitinated Proteins | 2009 |
Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case-control study.
Topics: Adult; Aged; Asian People; Breast Neoplasms; Case-Control Studies; Catechin; Female; Flavonoids; Humans; Japan; Logistic Models; Middle Aged; Odds Ratio; Phenols; Polyphenols; Prospective Studies; Risk Assessment; Risk Factors; Surveys and Questionnaires; Tea; Time Factors | 2010 |
(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Topics: Basigin; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Phosphorylation; RNA, Messenger; Signal Transduction; Tamoxifen; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2011 |
Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Carrier Proteins; Catechin; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Extracellular Matrix Proteins; Extracellular Signal-Regulated MAP Kinases; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Matrix Metalloproteinase 9; NF-kappa B; RNA, Messenger; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor AP-1 | 2010 |
Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Binding Sites; Breast Neoplasms; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Male; Mice; Mice, Inbred BALB C; Oxidative Stress; Promoter Regions, Genetic; Time Factors; Transcription, Genetic; Transfection; Tumor Burden | 2010 |
Inhibition of catechol-Omicron-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG.
Topics: Apoptosis; Breast Neoplasms; Carcinoma; Catechin; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cell Proliferation; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Female; Flavonoids; Humans; Phenols; Polyphenols; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Tea; Tumor Cells, Cultured | 2010 |
In vitro mechanism of action for the cytotoxicity elicited by the combination of epigallocatechin gallate and raloxifene in MDA-MB-231 cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catechin; Cell Line, Tumor; ErbB Receptors; Estrogen Receptor alpha; Female; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Raloxifene Hydrochloride; Receptor, ErbB-2; Ribosomal Protein S6 Kinases; Selective Estrogen Receptor Modulators; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases; Transcription Factor RelA | 2010 |
Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells.
Topics: Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; DNA Methylation; Drug Synergism; Estrogen Receptor alpha; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Polymerase Chain Reaction; Promoter Regions, Genetic; Tamoxifen | 2010 |
Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Breast Neoplasms; Catechin; Cell Survival; Fatty Acid Synthases; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Prognosis; Receptor, ErbB-2 | 2010 |
Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Catechin; Cell Adhesion; Cell Line, Tumor; Down-Regulation; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Female; Fibronectins; Focal Adhesion Kinase 1; Gene Silencing; Humans; Integrin alpha5beta1; Matrix Metalloproteinase 9; Neoplasm Proteins; Phosphorylation; Protein Processing, Post-Translational; RNA, Messenger; RNA, Small Interfering; Signal Transduction | 2011 |
A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; DNA Modification Methylases; Epigenesis, Genetic; Female; Flow Cytometry; Histone Acetyltransferases; Humans; Prodrugs; Promoter Regions, Genetic; Telomerase | 2011 |
The anti-cancer effects of (-)-epigallocatechin-3-gallate on the signaling pathways associated with membrane receptors in MCF-7 cells.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Calcium; Catechin; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Membrane Proteins; Signal Transduction | 2011 |
Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis.
Topics: Benzo(a)pyrene; Breast Neoplasms; Catechin; Cell Proliferation; Cells, Cultured; DNA Damage; Extracellular Signal-Regulated MAP Kinases; Female; Humans; MAP Kinase Signaling System; Nitrosamines; Reactive Oxygen Species; Tea | 2012 |
Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Catechin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Chemotherapy, Adjuvant; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Invasiveness; NF-kappa B; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-met; Tea; Vascular Endothelial Growth Factor A | 2012 |
Intervention of human breast cell carcinogenesis chronically induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Topics: Base Sequence; Breast Neoplasms; Carcinogens; Catechin; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Primers; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells.
Topics: Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; Down-Regulation; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase 1; HSP90 Heat-Shock Proteins; Humans; Nuclear Receptor Co-Repressor 1; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; RNA Polymerase II; Signal Transduction; Tea | 2013 |
Inhibition of fibroblast growth factors by green tea.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Breast Neoplasms; Catechin; Cells, Cultured; Endothelium, Vascular; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Humans; Neovascularization, Pathologic; Plant Extracts; RNA, Messenger; Tea | 2002 |
Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47D.
Topics: Breast Neoplasms; Carrier Proteins; Catechin; CDC2-CDC28 Kinases; Cell Division; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Cyclins; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Tumor Cells, Cultured | 2002 |
Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Breast Neoplasms; Carcinoma; Catechin; Cell Division; Cell Line, Tumor; Cyclin D1; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Genes, Reporter; Head and Neck Neoplasms; Humans; Immunoblotting; Luciferases; Paclitaxel; Phosphorylation; Prognosis; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Receptor, ErbB-2; Signal Transduction; Time Factors | 2003 |
EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Breast Neoplasms; Catalytic Domain; Catechin; Cell Division; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Flow Cytometry; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Telomerase; Time Factors | 2004 |
Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Humans; Tamoxifen | 2004 |
Green tea polyphenol epigallocatechin-3 gallate (EGCG) affects gene expression of breast cancer cells transformed by the carcinogen 7,12-dimethylbenz[a]anthracene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Anticarcinogenic Agents; Breast Neoplasms; Carcinogens; Catechin; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2005 |
The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
Topics: Antioxidants; Breast; Breast Neoplasms; Catechin; Dose-Response Relationship, Drug; Female; Hepatocyte Growth Factor; Humans; Neoplasm Invasiveness; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Receptors, Growth Factor; Signal Transduction; Tumor Cells, Cultured | 2006 |
Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1.
Topics: Blotting, Western; Breast Neoplasms; Catechin; Cell Line; Cell Line, Tumor; Cell Movement; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genes, Reporter; High Mobility Group Proteins; Humans; Models, Biological; Phosphorylation; Plasmids; Proto-Oncogene Proteins c-myc; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Signal Transduction; Tea; Time Factors; Transcription, Genetic; Transfection; Wnt Proteins | 2006 |
Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Catechin; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Flavonoids; G1 Phase; Guanosine Triphosphate; Humans; Immunohistochemistry; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Phenols; Polyphenols; Proliferating Cell Nuclear Antigen; Tea; Xenograft Model Antitumor Assays | 2007 |
Epigallocatechin gallate, the main ingredient of green tea induces apoptosis in breast cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Caspases; Catechin; Cell Cycle; Comet Assay; Flow Cytometry; Humans; Tumor Cells, Cultured | 2006 |
(-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Caspase 7; Caspase Inhibitors; Catechin; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Etoposide; Heat-Shock Proteins; Humans; Mice; Molecular Chaperones; Protein Conformation; Urinary Bladder Neoplasms | 2006 |
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Survival; Cisplatin; Down-Regulation; Doxorubicin; Etoposide; Female; HeLa Cells; Humans; Inhibitor of Differentiation Protein 1; Liver Neoplasms; Male; Mechlorethamine; Methotrexate; Mitomycin; Nasopharyngeal Neoplasms; Paclitaxel; Prostatic Neoplasms; Vincristine | 2007 |
Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodifying response on tumors in vivo? A pilot study with murine breast carcinoma.
Topics: Animals; Apoptosis; Breast Neoplasms; Carcinoma; Catechin; Cell Proliferation; Cells, Cultured; Combined Modality Therapy; Dietary Supplements; Female; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Pilot Projects; Radiation-Protective Agents; Vitamin E | 2007 |
Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Catechin; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Humans; Necrosis; Reactive Oxygen Species | 2007 |
A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Catechin; Cell Growth Processes; Cell Line, Tumor; Chromatography, High Pressure Liquid; Chymotrypsin; Female; Humans; Mice; Mice, Nude; Peracetic Acid; Prodrugs; Protease Inhibitors; Xenograft Model Antitumor Assays | 2007 |
Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Flow Cytometry; Humans; Tamoxifen | 2007 |
Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Topics: Breast Neoplasms; Catechin; Cell Line, Tumor; Fatty Acid Synthases; Gene Expression Regulation, Enzymologic; Humans; Mitogen-Activated Protein Kinases; Neuregulin-1; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Tea | 2007 |
Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.
Topics: Adenocarcinoma; Apoptosis; Breast Neoplasms; Catechin; Cell Division; Cell Line, Tumor; DNA Methylation; E2F1 Transcription Factor; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histones; HL-60 Cells; Humans; Lysine; Male; Methylation; Neoplasm Proteins; Promoter Regions, Genetic; Protein Processing, Post-Translational; RNA, Messenger; RNA, Neoplasm; Telomerase | 2008 |
Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells.
Topics: Animals; Anticarcinogenic Agents; Beverages; Breast Neoplasms; Cadherins; Catechin; Estrogen Receptor alpha; Female; Flavonoids; Forkhead Box Protein O3; Forkhead Transcription Factors; gamma Catenin; Gene Expression; Gene Expression Profiling; Humans; Immunoblotting; Neoplasm Invasiveness; Neoplasm Proteins; Phenols; Phenotype; Polyphenols; Receptor, ErbB-2; Reverse Transcriptase Polymerase Chain Reaction; Snail Family Transcription Factors; Transcription Factors; Transfection | 2007 |
Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Topics: Anticarcinogenic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Catechin; Cell Line, Tumor; Colony-Forming Units Assay; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Luciferases; Microtubule-Associated Proteins; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Promoter Regions, Genetic; Protease Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Survivin | 2007 |
Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.
Topics: 4-Butyrolactone; Apoptosis; Breast Neoplasms; Carnitine O-Palmitoyltransferase; Catechin; Enzyme Inhibitors; Fatty Acid Synthases; Fatty Acids; Female; Humans; Signal Transduction | 2008 |
Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Catechin; Cell Growth Processes; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Intracellular Signaling Peptides and Proteins; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Signal Transduction; Trastuzumab | 2007 |
Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase.
Topics: Adenosine Triphosphate; Breast Neoplasms; Catechin; Cell Proliferation; Dose-Response Relationship, Drug; Ellagic Acid; Endothelial Cells; Humans; Neovascularization, Pathologic; Nucleoside-Diphosphate Kinase; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Tumor Cells, Cultured | 2007 |
Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells.
Topics: Adenocarcinoma; Apoptosis; Apoptosis Regulatory Proteins; beta Catenin; Breast Neoplasms; Catechin; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Phenols; Phosphorylation; Polyphenols; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Tea | 2007 |
(-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Survival; Down-Regulation; Estrogen Receptor alpha; Female; Humans; Tamoxifen; Trefoil Factor-1; Tumor Suppressor Proteins | 2007 |
The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Catechin; Cell Division; Cell Line, Tumor; Curcumin; ErbB Receptors; Estrogen Receptor alpha; Female; Flow Cytometry; Humans; Mice; Mice, Nude; Oncogene Protein v-akt; Organ Size; Vascular Endothelial Growth Factor Receptor-1; Weight Gain | 2008 |
Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Catechin; Cell Division; Cell Line; Female; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Structure-Activity Relationship; Tea; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured | 1995 |
Influence of drinking green tea on breast cancer malignancy among Japanese patients.
Topics: Adult; Alcohol Drinking; Anticarcinogenic Agents; Beverages; Breast Neoplasms; Catechin; Diet; Disease-Free Survival; Female; Follow-Up Studies; Humans; Japan; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Smoking; Tea | 1998 |
Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts.
Topics: Anticarcinogenic Agents; Apoptosis; Breast; Breast Neoplasms; Catechin; Cell Division; Cell Line, Transformed; Cells, Cultured; Colon; Colonic Neoplasms; Female; Fibroblasts; Gene Expression; Genes, fos; Genes, myc; Humans; Microscopy, Fluorescence; Neoplasms; RNA, Messenger; Tea; Tumor Cells, Cultured | 1998 |
Green tea and cancer chemoprevention.
Topics: 3T3 Cells; Animals; Apoptosis; Biological Availability; Breast Neoplasms; Case-Control Studies; Catechin; Drug Synergism; Female; Humans; Japan; Male; Mice; Neoplasms; Sulindac; Tea; Tissue Distribution; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
Growth factor-dependent induction of p21(CIP1) by the green tea polyphenol, epigallocatechin gallate.
Topics: Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Catechin; Cell Cycle; Cell Line; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Epidermal Growth Factor; Growth Substances; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Retinoblastoma Protein; Signal Transduction; Tea; Time Factors | 2000 |
Green tea and its catechins inhibit breast cancer xenografts.
Topics: Animals; Breast Neoplasms; Catechin; Cell Division; Cells, Cultured; Endothelium, Vascular; Humans; Mice; Mice, SCID; Plant Extracts; Tea; Transplantation, Heterologous; Umbilical Veins | 2001 |
Diet and breast cancer.
Topics: Animals; Breast Neoplasms; Catechin; Cattle; Coumaric Acids; Cyclohexenes; Dehydroepiandrosterone; Diet; Female; Genistein; Humans; Indoles; Isothiocyanates; Limonene; Milk; Terpenes | 2002 |